Why Invest in Biotechnology, and How?
Britain and Germany Compared "
Germany and the UK have the most highly developed biotechnology structures in Europe, as well as distinctive policy structures. This paper considers those policy structures in the two countries in terms of basic expenditure on research and development and examines policies to stimulate private sector involvement, commercialisation and clustering. It pulls together the literature search and the overview of policy to highlight the key "critical success framework" in each country. By Rebecca Harding for the Anglo-German Foundation.
By Anglo-German Foundation , Germany, UK
Science and technology Policy Resource.